Mitigating Risk When Practicing Addiction Psychiatry-View Presentation

Video Transcription

Video Summary

This presentation focuses on the ethical, policy, and legal considerations when addressing addiction psychiatry. It explores the risk management and liability exposures when practicing addiction psychiatry, as well as risk management considerations when treating high-risk populations. The presentation also discusses the definition of addiction and the treatment approaches for addiction. It mentions the opioid crisis in the United States and the government's efforts to combat it. There is a shortage of psychiatrists available to treat individuals with substance use disorders, and efforts are being made to address this shortage through residency training programs and alternative treatment methods. The presentation also covers various laws related to addiction, such as the SUPPORT Act, the 21st Century Cures Act, and the Mental Health Parity and Addiction Equity Act. It highlights the importance of confidentiality protections in substance abuse treatment and provides guidelines for informed consent and documentation. The use of naloxone, an FDA-approved medication for opioid overdose, is discussed, as well as the requirements for DEA inspections for data-waivered physicians. The presentation emphasizes the importance of following federal and state regulations, obtaining informed consent, implementing prescription drug monitoring programs, and properly documenting all aspects of treatment.

Keywords

addiction psychiatry

opioid crisis

residency training programs

confidentiality protections

informed consent

documentation

naloxone

DEA inspections

prescription drug monitoring programs